Cadila
-
{
- All
- News
- Videos
- Web Stories
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government
Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.
-
Zydus Cadila Gets US Approval To Market Generic Schizophrenia Drug
Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic drug Cariprazine capsules, which are used in the treatment of schizophrenia.
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
South Korea's Enzychem To Make Cadila's COVID-19 Shot
South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare, the Indian drugmaker said on Wednesday.
-
Zydus Cadila Gets Final Approval From US FDA For Pre-Surgery Injection
India-based pharma giant, Zydus Cadila received final approval from US Food and Drug Administration (FDA) for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
-
India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each
The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.
-
60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report
As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre
Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Biological E Gets Drug Regulator's Approval For Phase 2nd, 3rd Trial On Children
The permission has been given to Biological E after the recommendation from the Subject Expert Committee.
-
Jabs For Children (12-17) From October In Zydus Cadila Rollout: Official
Details for the vaccination of children between 12 and 17 years of age, including prioritising those with comorbidities, will be made public before the Zydus Cadila vaccine is rolled out in October, Dr NK Arora said
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
Zydus Cadila's US Firm Gets US Approval To Market Roflumilast Tablets
Cadlia Healthcare Ltd on Monday said group firm Zydus Pharmaceuticals (USA) Inc has received final approval from the US health regulator to market its generic version of Roflumilast tablets in the strength of 500 mcg indicated to reduce the risk of
-
Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government
Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.
-
Zydus Cadila Gets US Approval To Market Generic Schizophrenia Drug
Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator to market generic drug Cariprazine capsules, which are used in the treatment of schizophrenia.
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
South Korea's Enzychem To Make Cadila's COVID-19 Shot
South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare, the Indian drugmaker said on Wednesday.
-
Zydus Cadila Gets Final Approval From US FDA For Pre-Surgery Injection
India-based pharma giant, Zydus Cadila received final approval from US Food and Drug Administration (FDA) for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
-
India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each
The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.
-
60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report
As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
-
Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre
The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.
-
This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'
Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.
-
Talks On To Make Covid DNA Vaccine Part Of Inoculation Drive: Centre
Preparations are on to make Zydus Cadila's COVID-19 DNA vaccine available to people and although the price is a "clear issue", a decision will be taken soon to make it a part of the country's vaccination programme, the government said on Thursday.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Biological E Gets Drug Regulator's Approval For Phase 2nd, 3rd Trial On Children
The permission has been given to Biological E after the recommendation from the Subject Expert Committee.
-
Jabs For Children (12-17) From October In Zydus Cadila Rollout: Official
Details for the vaccination of children between 12 and 17 years of age, including prioritising those with comorbidities, will be made public before the Zydus Cadila vaccine is rolled out in October, Dr NK Arora said
